Updates

Medplus Health Services Limited September 10, 2026 The Listing Department The Listing Department BSE Limited N ational Stock Exchange of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai – 400001 Bandra - Kurla Complex Bandra (East), Mumbai – 400051 BSE Scrip Code: 543427 NSE Symbol: MEDPLUS Dear Sir/Madam, Sub: Board's Comments on Non-Compliance under Regulation 17(1A) of SEBI (LODR) Regulations, 2015 This is with reference to the communication received from the Exchanges in accordance with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 (“Master Circular”) issued on July 11, 2023 and last updated on January 30, 2026 regarding the non-compliance identified by the Exchanges in respect of provisions of Regulation 17(1A) of SEBI LODR Regulations, 2015 with regard to appointment of Mr. Ajit Pandurang Rangnekar (DIN: 01676516) as Non-Executive- Independent Director who has attained the age of seventy five years. In accordance with the said communication from the Exchanges, the matter relating to the aforesaid non- compliance and the fine levied by the Exchanges was placed before the Board of Directors of the Company at its meeting held today i.e. Thursday, 10th September 2026 for its consideration and comments, if any. The Board, after due consideration of the matter, noted the observations of the Exchanges and the circumstances relating to the aforesaid non-compliance and commented as follows: “The Board has taken note of the non-compliance identified by the Exchanges and the fine levied in this regard. The Board noted that the non-compliance occurred on account of a bona fide interpretational difference regarding the applicability of the relevant provision, rather than any willful or process-related default. Further noted that, the proposal of such appointment was already placed in Annual General Meeting held on 17th August 2026 and same was approved by shareholders of the Company as special resolution. Hence the requirement for special resolution approval by shareholders of the Company has been complied. Further the Board has directed the management to ensure adherence to all applicable governance requirements and to further strengthen the relevant systems and processes so as to prevent recurrence of such non-compliance in the future.” The Company hereby submits the above Board comments to the Exchanges for your information, in accordance with the requirements communicated by the Exchanges. Kindly take the same on records. For MedPlus Health Services Limited Shrenik Soni Company Secretary & Compliance Officer M. No. F12400 040-6724 6724 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com